BIOMAT Database Logo BIOMAT Database Logo

Similar ability of FbaA with M protein to elicit protective immunity against group A streptococcus challenge in mice. 2009

Cui Qing Ma, and Cai Hong Li, and Xiu Rong Wang, and Rui Hong Zeng, and Xiao Lin Yin, and Hui Dong Feng, and Lin Wei
Department of Immunology, Basic Medical College, Hebei Medical University, Shijiazhuang 050017, China.

Group A streptococcus (GAS), an important human pathogen, can cause various kinds of infections including superficial infections and potentially lethal infections, and the search for an effective vaccine to prevent GAS infections has been ongoing for many years. This paper compares the immunogenicity and immunoprotection of FbaA (an Fn-binding protein expressed on the surface of GAS) with that of M protein, the best immunogen of GAS. Assay for immune response showed that FbaA, similar to M protein, could induce protein-specific high IgG titer in BALB/c mice. Furthermore, following GAS challenge, the mice immunized with FbaA showed the same protective rate as those with M protein. These results indicate that FbaA is similar in ability to M protein in inducing protective immunity against GAS challenge in mice.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D005634 Fructose-Bisphosphate Aldolase An enzyme of the lyase class that catalyzes the cleavage of fructose 1,6-biphosphate to form dihydroxyacetone phosphate and glyceraldehyde 3-phosphate. The enzyme also acts on (3S,4R)-ketose 1-phosphates. The yeast and bacterial enzymes are zinc proteins. (Enzyme Nomenclature, 1992) E.C. 4.1.2.13. Aldolase,Fructosediphosphate Aldolase,Aldolase A,Aldolase B,Aldolase C,Fructose 1,6-Bisphosphate Aldolase,Fructose 1,6-Bisphosphate Aldolase, Class II,Fructose 1-Phosphate Aldolase,Fructose Biphosphate Aldolase,Fructosemonophosphate Aldolase,1,6-Bisphosphate Aldolase, Fructose,Aldolase, Fructose 1,6-Bisphosphate,Aldolase, Fructose 1-Phosphate,Aldolase, Fructose Biphosphate,Aldolase, Fructose-Bisphosphate,Aldolase, Fructosediphosphate,Aldolase, Fructosemonophosphate,Fructose 1 Phosphate Aldolase,Fructose 1,6 Bisphosphate Aldolase,Fructose Bisphosphate Aldolase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial

Related Publications

Cui Qing Ma, and Cai Hong Li, and Xiu Rong Wang, and Rui Hong Zeng, and Xiao Lin Yin, and Hui Dong Feng, and Lin Wei
Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice.
February 1996, The Journal of infectious diseases,
Cui Qing Ma, and Cai Hong Li, and Xiu Rong Wang, and Rui Hong Zeng, and Xiao Lin Yin, and Hui Dong Feng, and Lin Wei
Systemic immunization with streptococcal immunoglobulin-binding protein Sib 35 induces protective immunity against group: a Streptococcus challenge in mice.
September 2005, Vaccine,
Cui Qing Ma, and Cai Hong Li, and Xiu Rong Wang, and Rui Hong Zeng, and Xiao Lin Yin, and Hui Dong Feng, and Lin Wei
Protective immunity against Streptococcus pyogenes challenge in mice after immunization with fibronectin-binding protein.
December 2005, The Journal of infectious diseases,
Cui Qing Ma, and Cai Hong Li, and Xiu Rong Wang, and Rui Hong Zeng, and Xiao Lin Yin, and Hui Dong Feng, and Lin Wei
Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes.
August 2006, Vaccine,
Cui Qing Ma, and Cai Hong Li, and Xiu Rong Wang, and Rui Hong Zeng, and Xiao Lin Yin, and Hui Dong Feng, and Lin Wei
Recombinant hyaluronate associated protein as a protective immunogen against Streptococcus equi and Streptococcus zooepidemicus challenge in mice.
September 1999, Microbial pathogenesis,
Cui Qing Ma, and Cai Hong Li, and Xiu Rong Wang, and Rui Hong Zeng, and Xiao Lin Yin, and Hui Dong Feng, and Lin Wei
Fetal Macrophages Exposed to Salmonella Antigens Elicit Protective Immunity Against Overwhelming Salmonella Challenge in A Murine Model.
March 2021, Biomedicines,
Cui Qing Ma, and Cai Hong Li, and Xiu Rong Wang, and Rui Hong Zeng, and Xiao Lin Yin, and Hui Dong Feng, and Lin Wei
Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice.
April 2017, Microbial pathogenesis,
Cui Qing Ma, and Cai Hong Li, and Xiu Rong Wang, and Rui Hong Zeng, and Xiao Lin Yin, and Hui Dong Feng, and Lin Wei
Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus.
July 2023, NPJ vaccines,
Cui Qing Ma, and Cai Hong Li, and Xiu Rong Wang, and Rui Hong Zeng, and Xiao Lin Yin, and Hui Dong Feng, and Lin Wei
Conserved molecular chaperone PrsA stimulates protective immunity against group A Streptococcus.
February 2024, NPJ vaccines,
Cui Qing Ma, and Cai Hong Li, and Xiu Rong Wang, and Rui Hong Zeng, and Xiao Lin Yin, and Hui Dong Feng, and Lin Wei
A novel monoclonal antibody against FbaA can inhibit the binding of the complement regulatory protein factor H to group A streptococcus.
April 2011, Clinical and vaccine immunology : CVI,
Copied contents to your clipboard!